Status:
COMPLETED
Developing Newborn Screening for Infants With Primary Immunodeficiency
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
Immune System Diseases
Eligibility:
All Genders
Brief Summary
This study will explore screening for immunodeficiency diseases (diseases that cause problems in fighting infections). There is no method at present to screen all babies at birth for immunodeficiency....
Detailed Description
Study Objective: T cell receptor excision circles (TRECs) are episomal DNA circles excised from the T cell receptor genes during T cell maturation in the thymus. They do not replicate, so they are dil...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patient who has not yet received a BMT and who has defined PI or undefined PI with T cell lymphopenia.
- EXCLUSION CRITERIA:
- None.
Exclusion
Key Trial Info
Start Date :
June 2 2005
Trial Type :
OBSERVATIONAL
End Date :
April 13 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00113464
Start Date
June 2 2005
End Date
April 13 2007
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06510-8005